Whole blood leukocyte mitogen activated protein kinases activation differentiates intensive care unit patients with systemic inflammatory response syndrome and sepsis

Journal of Trauma - Injury, Infection and Critical Care

Volumn 62, Issue 4, 2007, Pages 805-811

  West, Michael A ^a   Koons, Ann ^a   Crandall, Marie ^a   Skinner, Ruby ^a   Worley, Marcie ^a   Shapiro, Michael B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; AGED; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTENSIVE CARE; LEUKOCYTE; MACROPHAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLOW CYTOMETRY; HUMANS; INTENSIVE CARE UNITS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PILOT PROJECTS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34247189135     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000259267.74789.9b     Document Type: Article

References (35)

1. Cerra FB. Infection, the inflammatory response, and multiple organ dysfunction. In Howard R, Simmons RL, eds. Surgical Infectious Diseases. Norwalk: Appleton & Lange; 1995:387-400.
2. Carrico CJ, Meakins JL, Fry DE, Meier RV. Multiple organ failure syndrome. Arch Surg. 1986;121:196-208.
3. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990's. J Am Med Assoc. 1994;271:226-233.
4. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-873.
5. Glauser MP, Heumann D, Baumgartner JD, Cohen J. Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin Infect Dis. 1994;18:S205-S216.
6. Pace JL, Russel SW. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. J Immunol. 1981;126:1863-1867.
7. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med. 2002; 30(Suppl 1):S1-S11.
8. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med. 2002;30(Suppl 1):S64-S73.
9. Li MH, Seatter SC, Manthei R, et al. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res. 1994;57:85-92.
10. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res. 2003;9:101-107.
11. Cavaillon JM. The nonspecific nature of endotoxin tolerance. Trends Microbiol. 1995;3:320-324.
12. Zuckerman SH, Evans GF. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol. 1992;140:513-519.
13. Munoz C, Carlet J, Fitting C, et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991;88:1747-1754.
14. Marie C, Fitting C, Muret J, et al. Interleukin 8 production in whole blood assays: is interleukin 10 responsible for the downregulation observed in sepsis? Cytokine. 2000;12:55-61.
15. Shahbazian LM, Jeevanandam M, Petersen SR. Release of proinflammatory cytokines by mitogen-stimulated peripheral blood mononuclear cells from critically ill multiple-trauma victims. Metabolism. 1999;48:1397-1401.
16. Flach R, Majetschak M, Heukamp T, et al. Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine. 1999;11:173-178.
17. Ertel W, Keel M, Bonaccio M, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma. 1995;39:879-885; discussion 885-887.
18. Williams MA, Withington S, Newland AC, Kelsey SM. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis. 1998;178:1421-1433.
19. Heagy W, Nieman K, Hansen C, et al. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg Infect (Larchmt). 2003;4:171-180.
20. Haupt W, Fritzsche H, Hohenberger W, Zirngibl H. Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg. 1996;162:769-776.
21. Granowitz EV, Porat R, Mier JW, et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol. 1993;151:1637-1645.
22. Majetschak M, Borgermann J, Waydhas C, et al. Whole blood tumor necrosis factor-alpha production and its relation to systemic concentrations of interleukin 4, interleukin 10, and transforming growth factor-beta1 in multiply injured blunt trauma victims. Crit Care Med. 2000;28:1847-1853.
23. Majetschak M, Flach R, Heukamp T, et al. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J Trauma. 1997;43:880-887.
24. Fabian TC, Croce MA, Fabian MJ, et al. Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: experimental results and clinical correlation. Surgery. 1995;118:63-72.
25. Heagy W, Hansen C, Nieman K, et al. Impaired ex vivo lipopolysaccharide- stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock. 2000;14:271-276; discussion 276-277.
26. Wilson CS, Seatter SC, Rodriguez JL, et al. In vivo endotoxin tolerance: impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but not SIRS. J Surg Res. 1997;69:101-106.
27. Majetschak M, Christensen B, Obertacke U, et al. Sex differences in posttraumatic cytokine release of endotoxin-stimulated whole blood: relationship to the development of severe sepsis. J Trauma. 2000; 48:832-839; discussion 839-840.
28. Keel M, Schregenberger N, Steckholzer U, et al. Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma. 1996;41:430-437; discussion 437-438.
29. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250-1256.
30. Moriwaki Y, Sugiyama M, Ozawa Y, et al. Changes in the response of neutrophils to endotoxin priming following major abdominal surgery. World J Surg. 2002;26:521-526.
31. Sietses C, Wiezer MJ, Eijsbouts QA, et al. The influence of laparoscopic surgery on postoperative polymorphonuclear leukocyte function. Surg Endosc. 2000;14:812-816.
32. Heagy W, Hansen C, Nieman K, et al. Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxintolerant human monocytes. J Trauma. 2000;49:806-814.
33. West MA, Bennet T, Seatter SC, et al. LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation. J Leukoc Biol. 1997;61:88-95.
34. West MA, LeMieur T, Clair L, et al. Protein kinase C regulates macrophage tumor necrosis factor secretion: direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance. Surgery. 1997;122:204-211; discussion 211-212.
35. van der Poll T, Coyle SM, Moldawer LL, Lowry SF. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of healthy humans to endotoxin. J Infect Dis. 1996; 174:1356-1360.